By Adam Lidgett ( June 16, 2022, 8:35 PM EDT) -- Biogen has urged the U.S. Supreme Court to revive its patent on the blockbuster multiple sclerosis drug Tecfidera, saying the Federal Circuit invalidated it using an improper rule not found in the Patent Act requiring patents to demonstrate an invention is effective....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.